Skip to main content

Table 1 Baseline data

From: Impact of goal-directed hemodynamic management on the incidence of acute kidney injury in patients undergoing partial nephrectomy: a pilot randomized controlled trial

 

Intervention group (n = 72)

Control group (n = 72)

ASD

Age (years)

54.1 ± 12.1

54.5 ± 12.3

0.028

Male gender

48 (66.7%)

43 (59.7%)

0.144

Body Mass Index (kg/m2)

25.2 ± 3.3

25.0 ± 3.4

0.040

Comorbidity

 Hypertension

26 (36.1%)

34 (47.2%)

0.227

 Diabetes

13 (18.1%)

12 (16.7%)

0.037

 Respiratory diseasesa

2 (2.8%)

7 (9.7%)

0.290

 Othersb

6 (8.3%)

5 (6.9%)

0.052

Hemoglobin (g/L)

144.1 ± 15.2

142.8 ± 14.8

0.086

Albumin (g/L)

44.9 ± 3.5

44.3 ± 4.2

0.153

eGFR (mL/min/1.73 m2)c

83 ± 18

84 ± 14

0.134

Baseline SBP (mmHg)d

132 ± 17

139 ± 19

0.397

Baseline MAP (mmHg)d

96 ± 13

99 ± 12

0.228

Baseline HR (bpm)d

73 ± 9

72 ± 10

0.084

ASA classification

  

0.057

 1

32 (44.4%)

30 (41.7%)

 

 2

36 (50.0%)

38 (52.8%)

 

 3

4 (5.6%)

4 (5.6%)

 

Maximal mass diameter (cm)

2.8 (2.2, 4.0)

3 (2.1, 4.2)

0.109

PADUA scoree

7.5 ± 1.1

7.5 ± 1.0

0.013

Histology of cancerf

  

0.092

 Clear cell carcinoma

49 (68.1%)

50 (69.4%)

 

 Angiomyolipoma

15 (20.8%)

9 (12.5%)

 

 Othersg

8 (11.1%)

13 (18.1%)

 
  1. Data are mean ± SD, number (%), or median (interquartile range)
  2. ASD absolute standardized difference (an ASD of ≥0.327 is considered imbalanced between the two groups), eGFR estimated glomerular filtration rate, SBP systolic blood pressure, MAP mean arterial pressure, HR heart rate, PADUA Preoperative Aspects and Dimensions Used for an Anatomical scores
  3. aIncluded asthma (2 patients), chronic obstructive pulmonary disease (1 patient), obstructive sleep apnea (3 patients), history with lobectomy (2 patients), metastatic lung cancer (1 patient)
  4. bIncluded coronary atherosclerotic heart disease (3 patients), gout (3 patients), lower limb artery thrombosis (1 patient), vasovagal syncope (1 patient), and liver disease (3 patients)
  5. cCalculated according to the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation [22]
  6. dMeasured in the operating room before anesthesia induction
  7. ePADUA scores, a simple anatomical system used to predict the risk of perioperative surgical and medical complications in patients undergoing nephron-sparing surgery. The score ranges from 6 to 14, a score ≥ 8 indicates higher risk of complications [20]
  8. fAccording to pathological examination after surgery
  9. gIncluded chromophobe cell carcinoma (2 patients), papillary carcinoma (4 patients), malignant epithelial tumor (2 patients), cystic lesions (4 patients), oncocytic carcinoma (3 patients), unclassified renal cell carcinoma (5 patients), and inflammatory lesion (1 patient)
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us